At the time of writing, Vaxcyte Inc [PCVX] stock is trading at $74.81, up 1.25%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PCVX shares have gain 0.79% over the last week, with a monthly amount drifted -13.53%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vaxcyte Inc [NASDAQ: PCVX] stock has seen the most recent analyst activity on December 20, 2024, when Goldman initiated its Buy rating and assigned the stock a price target of $135. Previously, Mizuho started tracking the stock with Buy rating on December 07, 2023, and set its price target to $69. On April 18, 2023, TD Cowen initiated with a Outperform rating. Needham reiterated its Buy rating and increased its price target to $58 on January 03, 2023. Guggenheim initiated its recommendation with a Buy and recommended $66 as its price target on December 15, 2022. BTIG Research started tracking with a Buy rating for this stock on November 17, 2022, and assigned it a price target of $69.
For the past year, the stock price of Vaxcyte Inc fluctuated between $58.10 and $121.06. Currently, Wall Street analysts expect the stock to reach $148 within the next 12 months. Vaxcyte Inc [NASDAQ: PCVX] shares were valued at $74.81 at the most recent close of the market. An investor can expect a potential return of 97.83% based on the average PCVX price forecast.
Analyzing the PCVX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.17 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 71.81 points at the first support level, and at 68.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 77.10, and for the 2nd resistance point, it is at 79.38.
Ratios To Look Out For
It is important to note that Vaxcyte Inc [NASDAQ:PCVX] has a current ratio of 12.75. Further, the Quick Ratio stands at 12.75, while the Cash Ratio is 2.77.
Transactions by insiders
Recent insider trading involved Eydelman Mikhail, Officer, that happened on Mar 05 ’25 when 5000.0 shares were purchased. CHIEF OPERATING OFFICER, Wassil Jim completed a deal on Mar 03 ’25 to sell 8000.0 shares. Meanwhile, Officer Wassil Jim bought 8000.0 shares on Mar 03 ’25.
